Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 Trial

✍ Scribed by Okines, A. F. C.; Ashley, S. E.; Cunningham, D.; Oates, J.; Turner, A.; Webb, J.; Saffery, C.; Jo Chua, Y.; Chau, I.

• Book ID: 125531661
• Publisher: American Society of Clinical Oncology
• Year: 2010
• Tongue: English
• Weight: 122 KB
• Volume: 28
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2010.29.2847